Axiom Analytical Inc. Awarded
ISO 9001:2008 Certification
Axiom Analytical Inc. has announced
that it has been awarded certification
under the International Standards Organization (ISO) 9001:2008 standard.
“Meeting the requirements of ISO
9001:2008 has required the institution of
new management systems over and
above the company’s already comprehensive product quality assurance procedures,” said Dr. W. Michael Doyle,
Axiom’s CEO. “Since its inception,
Axiom has rigorously maintained procedures ensuring meticulous product documentation and testing. Meeting the ISO
9001:2008 requirements has involved integrating these into a strengthened overall framework, encompassing all aspects
of the business from personnel hiring
and training to vendor qualification. The
ISO 9001:2008 framework provides a
sound foundation for Axiom Analytical’s growth combined with its continued high level of customer service.”
Food Safety Net Services and
AdvancePierre Foods Partner on
Food Safety Testing Programs
Food Safety Net Services (FSNS) has
entered into a strategic partnership with
AdvancePierre Foods to provide out-
sourced laboratory testing, consultation
and general food safety programs.
Bill Toler, CEO of AdvancePierre
Foods, stated, “Food safety has always
been a top priority for AdvancePierre
Foods, and we are proud of our excellent
record. We are pleased to partner with
FSNS to add an extra layer of support
and testing above and beyond our cur-
rent programs, providing even more con-
fidence for our growing customer base.”
FSNS’s national network of laborato-
ries adheres to the highest standard of
certification through the international
ISO/IEC 17025 standard by the Ameri-
can Association for Laboratory Accredi-
tation. Gina Bellinger, president of
FSNS, stated, “We are extremely proud
to be associated and selected by
AdvancePierre to be their exclusive
partner for food testing services.”
Sartorius Signs Private Label
Agreement with Dylog
Sartorius, an international laboratory
and process equipment provider, has entered into
a private
label agreement with the Italian technology and
software supplier Dylog. The agreement
covers global sales, marketing and distri-
bution activities for the entire range of
Dylog X-ray inspection and detection
equipment under the Sartorius brand
name. Furthermore, Sartorius will assume servicing and installation of these
private-label products.
Hypred Rebrands Its U.S. Food &
Beverage Sanitation Division
Capitalizing on the strength of its
reputation around the world, Hypred
Ltd. is rebranding its U.S.-based A&L
Laboratories Food Division—the part of
A&L Laboratories that serves the food
and beverage processing industry—as
Hypred USA. Aligning with its global
parent signifies the A&L Laboratories
Food Division’s ability to grow and serve
customers beyond the Midwest, which
has been the company’s primary base of
operations since entering the food and
beverage processing industry.
Operating in the U.S. since 1948 as
A&L Laboratories, the company has established a reputation as a reliable
provider of innovative technologies and
application expertise for sanitation in
the food and beverage processing industry. It is the leader in single-step cleaning
technologies that maximize efficient use
of a plant’s water, energy and time
resources.
The U.S. Food and Drug Administration (FDA) has
released draft guidance to provide regulated industries, including food, with greater certainty about the use of nanotechnology, which generally involves materials made up of
particles that are at least one billionth of a meter in size. The
guidance outlines the agency’s view on whether regulated
products contain nanomaterials or involve the application of
nanotechnology.
Nanotechnology, the science involving manipulation of
materials on an atomic or molecular scale, is an emerging
technology with a broad range of potential applications, such
as improving food packaging.
The draft guidance represents the first step toward providing regulatory clarity on FDA’s approach to nanotechnology.
Specifically, FDA named certain characteristics, such as the
size of nanomaterials used and the exhibited properties of
those materials, which may be considered when attempting to
identify applications of nanotechnology in regulated
products.
“With this guidance, we are not announcing a regulatory
FDA Takes ‘First Step’ Toward Greater Regulatory Certainty
around Nanotechnology
definition of nanotechnology,” said Margaret A. Hamburg,
M.D., Commissioner of Food and Drugs. “However, as a first
step, we want to narrow the discussion to these points and
work with industry to determine if this focus is an appropriate
starting place.”
In 2006, FDA formed the Nanotechnology Task Force,
charged with identifying and addressing ways to better enable
the agency to evaluate possible adverse health effects from
FDA-regulated nanotechnology products. It is critical for
FDA to understand how changes in physical, chemical or bio-
logical properties seen in nanomaterials affect the safety, ef-
fectiveness, performance or quality of a product that contains
such materials. FDA has a robust regulatory science agenda to
develop the tools, methods and expertise necessary to evalu-
ate products that contain nanomaterials or otherwise involve
the use of nanotechnology. FDA’s regulatory science portfo-
lio focuses on generating data needed to ensure the safety and
effectiveness of products using nanomaterials, with an em-
phasis on products the use of which could present the great-
est potential risk to public health.
